Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease and Parkinsonism”

2,405 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,405 results

Large-scale testing (Phase 3)Ended earlyNCT00865579
What this trial is testing

Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 964
Not applicableStudy completedNCT03531086
What this trial is testing

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

Who this might be right for
Parkinson Disease
Julie Gurwell 12
Not applicableUnknownNCT06430151
What this trial is testing

Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease

Who this might be right for
Parkinson Disease
Dr Alistair Mackett 20
Not applicableStudy completedNCT06389903
What this trial is testing

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease

Who this might be right for
Parkinson Disease
Centre Hospitalier du Rouvray 15
Not applicableStudy completedNCT02236286
What this trial is testing

Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 16
Testing effectiveness (Phase 2)Study completedNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 99
Testing effectiveness (Phase 2)Ended earlyNCT03306329
What this trial is testing

DNS-7801 vs. Placebo in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Dart NeuroScience, LLC 5
Not applicableStudy completedNCT03232996
What this trial is testing

Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.

Who this might be right for
Parkinson DiseaseParkinson
University of Manitoba 30
Large-scale testing (Phase 3)Ended earlyNCT01215227
What this trial is testing

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Merck Sharp & Dohme LLC 839
Not applicableEnded earlyNCT03922672
What this trial is testing

Piano Training, Caregivers, and Parkinson's Disease

Who this might be right for
DepressionMoodBurden, Dependency
University of Miami 14
Not applicableUnknownNCT06104072
What this trial is testing

Effect of Adding Computerized Cognitive Training on Balance, Locomotion and Cognition in Parkinson's Disease

Who this might be right for
Parkinson Disease
Engy Badreldin Saleh Moustafa, PhD 70
Post-approval studies (Phase 4)UnknownNCT05855577
What this trial is testing

Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

Who this might be right for
Parkinson DiseaseGait AnalysisTherapy, Directly Observed+1 more
I.R.C.C.S. Fondazione Santa Lucia 50
Large-scale testing (Phase 3)Study completedNCT02091739
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Who this might be right for
Chronic Troublesome SialorrheaParkinson's DiseasePost-stroke+1 more
Merz Pharmaceuticals GmbH 184
Not applicableActive Not RecruitingNCT04507139
What this trial is testing

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 50
Not applicableStudy completedNCT04273672
What this trial is testing

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

Who this might be right for
Parkinson DiseaseCognitive Impairment, MildSpeech
University of Massachusetts, Worcester 58
Not applicableUnknownNCT03454269
What this trial is testing

Role of Retina in Mechanisms of Illusions and Visual Hallucinations Observed in Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's DiseaseVisual Hallucinations
University Hospital, Clermont-Ferrand 90
Not applicableUnknownNCT03727529
What this trial is testing

Immersive Virtual Reality to Improve Gait in Parkinson's Disease

Who this might be right for
Parkinson DiseaseGait Disorders, Neurologic
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 46
Not applicableLooking for participantsNCT04735172
What this trial is testing

Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects

Who this might be right for
Parkinson's Disease
University Hospital, Clermont-Ferrand 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07414290
What this trial is testing

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations

Who this might be right for
Parkinson Disease (PD)
Shanghai Vitalgen BioPharma Co., Ltd. 17
Early research (Phase 1)Study completedNCT02071810
What this trial is testing

Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 34
Next Page